These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 2737240
21. Mechanisms of sex-steroid accumulation in the aetiology of human breast carcinoma: the role of intracellular sex hormone binding globulin. Iqbal MJ, Valyani SH, Roberts JV. Anticancer Res; 1988; 8(3):479-81. PubMed ID: 3389751 [Abstract] [Full Text] [Related]
22. [Evolution of plasma levels of SHBG (sex-hormone binding globulin) during ovulation induction using gonadotrophins]. Clair P, Claustrat B, Brun J, Dechaud H, Thoulon JM. J Gynecol Obstet Biol Reprod (Paris); 1985; 14(1):19-25. PubMed ID: 4040143 [Abstract] [Full Text] [Related]
23. A study of the endocrine manifestations of hepatic cirrhosis. Baker HW, Burger HG, de Kretser DM, Dulmanis A, Hudson B, O'Connor S, Paulsen CA, Purcell N, Rennie GC, Seah CS, Taft HP, Wang C. Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039 [Abstract] [Full Text] [Related]
24. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women. Falk RT, Gentzschein E, Stanczyk FZ, Garcia-Closas M, Figueroa JD, Ioffe OB, Lissowska J, Brinton LA, Sherman ME. Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130 [Abstract] [Full Text] [Related]
25. [Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)]. Reiner G, Bieglmayer C, Jakesz R, Kees A, Kolb R, Spona J. Wien Klin Wochenschr; 1981 May 29; 93(11):339-42. PubMed ID: 6791390 [Abstract] [Full Text] [Related]
26. Bioavailability of estradiol as a marker for breast cancer risk assessment. Jones LA, Ota DM, Jackson GA, Jackson PM, Kemp K, Anderson DE, McCamant SK, Bauman DH. Cancer Res; 1987 Oct 01; 47(19):5224-9. PubMed ID: 3621208 [Abstract] [Full Text] [Related]
27. Plasma sex hormone-binding globulin (SHBG) and obesity in breast cancer patients. Murayama Y. Cancer Detect Prev; 1983 Oct 01; 6(4-5):425-33. PubMed ID: 6686084 [Abstract] [Full Text] [Related]
28. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A, Lenner P. Cancer Causes Control; 2003 Sep 01; 14(7):599-607. PubMed ID: 14575357 [Abstract] [Full Text] [Related]
29. The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. Dowsett M, Lal A, Smith IE, Jeffcoate SL. Br J Cancer; 1987 Mar 01; 55(3):311-3. PubMed ID: 2952154 [Abstract] [Full Text] [Related]
30. The sex hormone profile of male patients with breast cancer. Nirmul D, Pegoraro RJ, Jialal I, Naidoo C, Joubert SM. Br J Cancer; 1983 Sep 01; 48(3):423-7. PubMed ID: 6684472 [Abstract] [Full Text] [Related]
31. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients. Lønning PE, Johannessen DC, Lien EA, Ekse D, Fotsis T, Adlercreutz H. J Steroid Biochem Mol Biol; 1995 May 01; 52(5):491-6. PubMed ID: 7748814 [Abstract] [Full Text] [Related]
32. Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancer. Geisler J, Haarstad H, Gundersen S, Raabe N, Kvinnsland S, Lønning PE. J Endocrinol; 1995 Aug 01; 146(2):359-63. PubMed ID: 7561649 [Abstract] [Full Text] [Related]
33. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis. Albers FEM, Lou MWC, Dashti SG, Swain CTV, Rinaldi S, Viallon V, Karahalios A, Brown KA, Gunter MJ, Milne RL, English DR, Lynch BM. Cancer Causes Control; 2024 Jun 01; 35(6):921-933. PubMed ID: 38363402 [Abstract] [Full Text] [Related]
34. Associations of sex steroid hormones with mortality in women with breast cancer. Duggan C, Stanczyk F, Campbell K, Neuhouser ML, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard R, McTiernan A. Breast Cancer Res Treat; 2016 Feb 01; 155(3):559-67. PubMed ID: 26865065 [Abstract] [Full Text] [Related]
35. Plasma concentrations of sex hormones in postmenopausal women in non-alcoholic cirrhosis. Bannister P, Sheridan P, Losowsky MS. Clin Endocrinol (Oxf); 1985 Oct 01; 23(4):335-40. PubMed ID: 2933194 [Abstract] [Full Text] [Related]
36. [Competitive binding assay with dextran-coated charcoal for measurement of sex hormone-binding globulin in breast cancer]. Suminaga Y, Sonoo H, Morimoto T. Nihon Geka Gakkai Zasshi; 1986 Mar 01; 87(3):341-9. PubMed ID: 2423861 [Abstract] [Full Text] [Related]
37. Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study. Gershagen S, Doeberl A, Jeppsson S, Rannevik G. Fertil Steril; 1989 Apr 01; 51(4):616-21. PubMed ID: 2924930 [Abstract] [Full Text] [Related]
38. Endogenous plasma sex hormones in pre- and postmenopausal women with breast cancer: results from a case-control study in Moscow. Zaridze D, Kushlinskii N, Moore JW, Lifanova Ye, Bassalyk L, Wang DY. Eur J Cancer Prev; 1992 Apr 01; 1(3):225-30. PubMed ID: 1467767 [Abstract] [Full Text] [Related]
39. Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients. Parlati E, Travaglini A, Liberale I, Menini E, Dell'Acqua S. J Endocrinol Invest; 1988 Oct 01; 11(9):679-83. PubMed ID: 2975693 [Abstract] [Full Text] [Related]
40. Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. Enriori CL, Orsini W, del Carmen Cremona M, Etkin AE, Cardillo LR, Reforzo-Membrives J. Gynecol Oncol; 1986 Jan 01; 23(1):77-86. PubMed ID: 3943755 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]